Evidence map›Paper›PMID 17304338›Full record

ArticleInternational journal of biological sciences2007

Mouse 24p3 protein has an effect on L929 cell viability.

Pei-Tzu Li, Ying-Chu Lee, Namasivayam Elangovan, Sin-Tak Chu

Open access · goldAbstract read
In one paragraph

Article in International journal of biological sciences, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Lipocalin 2: novel component of proinflammatory signaling in Alzheimer's disease.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2012
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Pei-Tzu LiInstitute of Biochemical Science, College of Life Science, National Taiwan University, Taipei, Taiwan.
Ying-Chu Lee
Namasivayam Elangovan
Sin-Tak Chu
Academia Sinica · TWInstitute of Biological Chemistry, Academia Sinica · TWNational Taiwan University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is well known that mouse uterine 24p3 protein, is an acute phase protein, secreted from the L929 cell line, and that it will be induced by the dexamethasone stimulation of the cell. We investigated the possible effects of 24p3 protein on the L929 cell line, by observing its morphological change, ROS increase and viability decrease, by the process of culturing in a 24p3 protein-supplemented medium. Following the L929 cells' exposure to the 24p3 protein supplement for a period of 72 hours, S-phase cells accumulated to a significant degree, suggesting that the entry into the G2/M phase from the S phase, in the cell cycle progression, was blocked. There was a significant decrease in cell numbers and increased DNA damage within the cells in the presence of 24p3 protein within the medium for 96 hours, implying that they have undergone pathway of cell death. After 96h incubation in low concentration of 24p3 protein, the result of PI/annexin V double staining showed cell death obviously. These results suggest that 24p3 protein-induced S phase arrest in the cell cycle, would cause DNA damage, followed by cell death in the L929 cells.

Indexed as

Acute-Phase ProteinsAnimalsBromodeoxyuridineCell CycleCell DeathCell LineCell ShapeCell SurvivalDNA DamageFemaleFlow CytometryInterphaseLipocalin-2LipocalinsMiceMicroscopy, FluorescenceAcute-Phase ProteinsBromodeoxyuridineLcn2 protein, mouseLipocalin-2LipocalinsOncogene ProteinsReactive Oxygen Species

Identifiers

PMID17304338
PMCPMC1796953
OpenAlexW2113582311

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.